TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32167837

Group type: EXPERIMENTAL
Intervention: Concentric exercise
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Concentric exercise with Blood Flow Restriction Training (BFRT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Eccentric exercise with Blood Flow Restriction Training (BFRT)
Number of subjects: 34
Study: 33655650

Group type: EXPERIMENTAL
Intervention: InnoSEAL
Number of subjects: 606

Group type: COMPARATOR
Intervention: PCD
Number of subjects: 606
Study: 33454706

Group type: EXPERIMENTAL
Intervention: Vedolizumab 300 mg
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study: 36399081

Group type: EXPERIMENTAL
Intervention: Autologous tooth bone powder
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inorganic bovine bone powder
Number of subjects: 60

Group type: COMPARATOR
Intervention: Negative control (no implants)
Number of subjects: 60
Study: 33461579

Group type: EXPERIMENTAL
Intervention: Prophylactic clipping after EMR
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control group (no prophylactic clipping)
Number of subjects: 356
Study: 32574181

Group type: EXPERIMENTAL
Intervention: Reminder designed to evoke emotional guilt
Number of subjects: 161587

Group type: EXPERIMENTAL
Intervention: Four additional reminder formats
Number of subjects: 161587

Group type: COMPARATOR
Intervention: Control group (generic message)
Number of subjects: 161587
Study: 36317349

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 230
Study: 33652093

Group type: EXPERIMENTAL
Intervention: Hospice representatives reporting knowledge and perceptions about medication shortages
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Hospice representatives reporting missing opioid medications
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Hospice representatives reporting disposal practices of medications after home deaths
Number of subjects: 600
Study: 35998172

Group type: EXPERIMENTAL
Intervention: surgical mask (sm)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FFP2 mask (ffpm)
Number of subjects: 12
Study: 33187916

Group type: EXPERIMENTAL
Intervention: Concurrent apatinib and brain radiotherapy (BR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Brain radiotherapy (BR) alone
Number of subjects: 90
Study: 34255168

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics in combination with cognitive remediation therapy (AP + CR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Atypical antipsychotics (AP)
Number of subjects: 15
Study: 32912058

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 478

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 478
Study: 35050837

Group type: EXPERIMENTAL
Intervention: RVT-1601 10 mg
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: RVT-1601 40 mg
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: RVT-1601 80 mg
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 32221654

Group type: EXPERIMENTAL
Intervention: Active tDCS (12 2 mA, 30‐min, anodal‐left, cathodal‐right prefrontal cortex)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 59
Study: 36149171

Group type: EXPERIMENTAL
Intervention: Pelvic stabilization exercises and TENS administered once daily for approximately 30 min during acute hospitalization
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Pelvic stabilization exercises and TENS
Number of subjects: 31
Study: 32937192

Group type: EXPERIMENTAL
Intervention: Intranasal Oxytocin (24 IU)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 32674676

Group type: EXPERIMENTAL
Intervention: Classical low-flow (CLF-LG)
Number of subjects: 3511

Group type: COMPARATOR
Intervention: High-gradient (HG)
Number of subjects: 3511

Group type: EXPERIMENTAL
Intervention: Normal-flow (LG)
Number of subjects: 3511

Group type: EXPERIMENTAL
Intervention: Paradoxical low-flow (LG)
Number of subjects: 3511
Study: 36168179

Group type: EXPERIMENTAL
Intervention: Telementored group
Number of subjects: 37

Group type: COMPARATOR
Intervention: Non-telementored group
Number of subjects: 37
Study: 36343030

Group type: EXPERIMENTAL
Intervention: Intravascular irradiation of blood (ILIB) combined with myofunctional exercises; ILIB treatment is performed twice a week for 8 weeks.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo ILIB combined with orofacial myofunctional therapy (MFT) exercise protocol; placebo treatment is performed twice a week for 8 weeks.
Number of subjects: 46
Study: 34018029

Group type: EXPERIMENTAL
Intervention: ibrutinib-obinutuzumab
Number of subjects: 228

Group type: COMPARATOR
Intervention: chlorambucil-obinutuzumab
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 228
Study: 35662408

Group type: EXPERIMENTAL
Intervention: Furmonertinib (80 mg/day)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Gefitinib (250 mg/day)
Number of subjects: 358
Study: 33002700

Group type: EXPERIMENTAL
Intervention: Membrane distillation (MD) powered by waste heat
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Membrane distillation (MD) powered by natural gas
Number of subjects: 20
Study: 36193750

Group type: EXPERIMENTAL
Intervention: Guideline-Directed Medical Therapy (GDMT) goals achieved
Number of subjects: 777

Group type: COMPARATOR
Intervention: Statin therapy
Number of subjects: 777

Group type: COMPARATOR
Intervention: Aspirin therapy
Number of subjects: 777
Study: 34731918

Group type: EXPERIMENTAL
Intervention: Infiltration with anesthetic solution and adjuvants (fentanyl, epinephrine, ketorolac)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo infiltration
Number of subjects: 40
Study: 35881302

Group type: EXPERIMENTAL
Intervention: 38% SDF
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 12% SDF
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 30% SDF
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (without SDF treatment)
Number of subjects: 40
Study: 34656740

Group type: EXPERIMENTAL
Intervention: Adjuvant abemaciclib combined with endocrine therapy (ET) for 2 years
Number of subjects: 5637
Study: 35477480

Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blockers with standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo with standard care
Number of subjects: 0
Study: 32740755

Group type: EXPERIMENTAL
Intervention: Genetic intelligence score (gIQ) increase of one standard deviation (SD)
Number of subjects: 461389

Group type: EXPERIMENTAL
Intervention: Genetic intelligence score (gIQ)
Number of subjects: 461389

Group type: EXPERIMENTAL
Intervention: Adjustment for measured intelligence and educational attainment
Number of subjects: 461389

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analyses
Number of subjects: 461389
Study: 36235549

Group type: EXPERIMENTAL
Intervention: Green Tea Extract (GTE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 32178925

Group type: COMPARATOR
Intervention: Basiliximab (20 mg D0 and D4)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Thymoglobulin (3 mg/kg total)
Number of subjects: 100
Study: 32673243

Group type: EXPERIMENTAL
Intervention: Smartphone-based vision screening solution
Number of subjects: 100
Study: 35041775

Group type: EXPERIMENTAL
Intervention: Brigatinib 180 mg once daily (7-day lead-in dose at 90 mg once daily)
Number of subjects: 0
Study: 34226082

Group type: EXPERIMENTAL
Intervention: Electromagnetic navigated surgery
Number of subjects: 127

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 127
Study: 34969498

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 1494

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1494
Study: 33179263

Group type: EXPERIMENTAL
Intervention: Galcanezumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36266558

Group type: EXPERIMENTAL
Intervention: 120 mg galcanezumab (240 mg loading dose)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: 240 mg galcanezumab
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: 120 mg galcanezumab
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study: 33881513

Group type: EXPERIMENTAL
Intervention: Anatomical testing
Number of subjects: 9572

Group type: COMPARATOR
Intervention: Functional testing
Number of subjects: 9572
Study: 32497520

Group type: EXPERIMENTAL
Intervention: 39·0°C ear temperature limit
Number of subjects: 269

Group type: COMPARATOR
Intervention: 38·5°C ear temperature limit
Number of subjects: 269
Study: 35048733

Group type: EXPERIMENTAL
Intervention: Rehabilitation therapy plus optional delayed ACL reconstruction
Number of subjects: 167

Group type: COMPARATOR
Intervention: Delayed ACL reconstruction
Number of subjects: 167

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 167
Study: 34036929

Group type: EXPERIMENTAL
Intervention: Referral aid for smoking cessation guidance provided by practice nurses (PNs) in accordance with the referral aid.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care without the referral aid (control condition).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Referral aid for smoking cessation guidance provided by practice nurses (PNs).
Number of subjects: 0
Study: 34076285

Group type: EXPERIMENTAL
Intervention: Hybrid suture pattern
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Figure‐8 suture pattern
Number of subjects: 16

Group type: COMPARATOR
Intervention: Simple interrupted suture pattern
Number of subjects: 16
Study: 32944934

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) monotherapy (800-1600 mg/d)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) monotherapy (ESL/ESL)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Controlled-release carbamazepine (CBZ-CR) followed by ESL monotherapy (CBZ-CR/ESL)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) monotherapy
Number of subjects: 206
Study: 35973827

Group type: EXPERIMENTAL
Intervention: MitoHeal® (500 mg/d)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MitoHeal® (1,000 mg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34328794

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (orthodontic intrusion without PBM)
Number of subjects: 20
Study: 36288558

Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride gel
Number of subjects: 220

Group type: COMPARATOR
Intervention: Sham gel
Number of subjects: 220
Study: 34156468

Group type: EXPERIMENTAL
Intervention: 30-minute nap opportunity
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 60-minute nap opportunity
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Participants who napped (30 or 60 minutes)
Number of subjects: 280

Group type: COMPARATOR
Intervention: No nap opportunity (control group)
Number of subjects: 280
Study: 32423509

Group type: EXPERIMENTAL
Intervention: Low-alcohol white wine (8.0% alcohol content)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard white wine (12.5% alcohol content)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low-alcohol white wine (8.0% alcohol content) - blinded condition
Number of subjects: 90
Study: 36109033

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Neuromuscular exercise (NEMEX)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Exercise booster sessions (EBS)
Number of subjects: 160
Study: 33525601

Group type: EXPERIMENTAL
Intervention: Nutraceutical combination (Bifidobacterium longum BB536, red yeast rice extract (10 mg/dose monacolin K))
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 32162958

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 53
Study: 36101936

Group type: EXPERIMENTAL
Intervention: AS04-HPV-16/18 vaccine
Number of subjects: 6051
Study: 33292693

Group type: EXPERIMENTAL
Intervention: iVERVE intervention (electronic support messages aligned to personal goals over 4 weeks)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (2-3 electronic administrative messages)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: iVERVE intervention
Number of subjects: 54
Study: 35166384

Group type: EXPERIMENTAL
Intervention: Fructans (40 g/500 mL saline)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Glucose (40 g/500 mL saline)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saline (500 mL)
Number of subjects: 13
Study: 33347776

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control (no hypothermia)
Number of subjects: 184
Study: 33731890

Group type: EXPERIMENTAL
Intervention: Inferomedial orbital decompression
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Balanced orbital decompression
Number of subjects: 42
Study: 34479145

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Compassionate Living (MBCL)
Number of subjects: 104
Study: 35549716

Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) intervention with free LPG stove, continuous fuel delivery, and regular behavioral messaging for the first year.
Number of subjects: 180

Group type: COMPARATOR
Intervention: Voucher-based LPG intervention for controls in the second year (free LPG stove, regular behavioral messaging, and vouchers for LPG tanks).
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Intervention participants after free fuel distribution stopped in the second year.
Number of subjects: 180
Study: 32078086

Group type: EXPERIMENTAL
Intervention: RY-NF (virtual mind-body group program)
Number of subjects: 51

Group type: COMPARATOR
Intervention: HE-NF (health education attention control)
Number of subjects: 51
Study: 35964137

Group type: EXPERIMENTAL
Intervention: Gln/Arg/HMB supplementation (2 sachets daily: 7 g l-arginine, 7 g l-glutamine, 1.5 g HMB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gln/Arg/HMB supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33378369

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 16167
Study: 34530475

Group type: EXPERIMENTAL
Intervention: Mizzou BioJoint Flex‐novel motion‐assistive device with prescribed physical therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard physical therapy
Number of subjects: 38
Study: 34831529

Group type: EXPERIMENTAL
Intervention: High resistance training volume-load
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Moderate resistance training volume-load
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low resistance training volume-load
Number of subjects: 33
Study: 34921960

Group type: EXPERIMENTAL
Intervention: A+CHP (brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone)
Number of subjects: 452

Group type: COMPARATOR
Intervention: CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin retreatment after A+CHP
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin after CHOP
Number of subjects: 452
Study: 33544556

Group type: EXPERIMENTAL
Intervention: Chest physiotherapy with a new airway clearance device (Simeox; PhysioAssist)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Chest physiotherapy alone
Number of subjects: 48
Study: 32784930

Group type: EXPERIMENTAL
Intervention: Tetrodotoxin (TTX) 15 µg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tetrodotoxin (TTX) 30 µg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tetrodotoxin (TTX) 45 µg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 25
Study: 34116816

Group type: EXPERIMENTAL
Intervention: DynamiCare along with treatment-as-usual (TAU; N = 29)
Number of subjects: 61

Group type: COMPARATOR
Intervention: TAU only (N = 32)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: DynamiCare
Number of subjects: 61
Study: 33444079

Group type: EXPERIMENTAL
Intervention: R-miniCHOP
Number of subjects: 249

Group type: COMPARATOR
Intervention: R2-miniCHOP
Number of subjects: 249
Study: 33572715

Group type: EXPERIMENTAL
Intervention: Cosmos caudatus supplement (250 mg of CC/capsule, twice daily for 12 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (500 mg maltodextrin/capsule, twice daily for 12 weeks)
Number of subjects: 48
Study: 32830940

Group type: EXPERIMENTAL
Intervention: Non-bag transfer set exchange procedure
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard bag exchange procedure
Number of subjects: 33
Study: 33452887

Group type: EXPERIMENTAL
Intervention: Clorpactin 0.4% solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cystoscopy/hydrodistension
Number of subjects: 50
Study: 32881834

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs)
Number of subjects: 12757

Group type: COMPARATOR
Intervention: Non-CHMs users
Number of subjects: 12757
Study: 35244373

Group type: EXPERIMENTAL
Intervention: Custodiol cardioplegia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Blood cardioplegia
Number of subjects: 20
Study: 36327028

Group type: EXPERIMENTAL
Intervention: Physical activity (standing, performing calf muscle contractions while standing, walking, and climbing stairs)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Inactivity (lying down and sitting)
Number of subjects: 8
Study: 34159198

Group type: EXPERIMENTAL
Intervention: Si foliar applied
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Si topdressing
Number of subjects: 0
Study: 32093665

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) oxygen therapy (50 L/min, FiO2 0.5)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Venturi mask (VM) oxygen therapy (15 L/min, FiO2 0.5)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) oxygen therapy (50 L/min, FiO2 0.5) in good responders
Number of subjects: 20

Group type: COMPARATOR
Intervention: Venturi mask (VM) oxygen therapy (15 L/min, FiO2 0.5) in good responders
Number of subjects: 20
Study: 71706451

Group type: EXPERIMENTAL
Intervention: Exercise plus water exercise (EW) group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Exercise (E) group
Number of subjects: 60
Study: 36106470

Group type: EXPERIMENTAL
Intervention: HP±1% quercetin for 10min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HP±10% sodium ascorbate for 10min
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HP±10% alpha‐tocopherol for 10min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bleaching with 40% hydrogen peroxide (HP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No bleaching (negative control)
Number of subjects: 60
Study: 33626480

Group type: EXPERIMENTAL
Intervention: Conjugate therapy (statin + ezetimibe)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Statin monotherapy
Number of subjects: 80
Study: 33028207

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) for 6 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ATP + 35 W exercise for 6 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ATP + 45 W exercise for 6 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increment of rate pressure product (RPP) after stress
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left ventricular end-diastolic volume (LVEDV) after stress
Number of subjects: 0
Study: 35603451

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35258371

Group type: EXPERIMENTAL
Intervention: 90Y transarterial radioembolization (TARE)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Doxorubicin drug-eluting bead (DEB) TACE
Number of subjects: 72
Study: 33198710

Group type: EXPERIMENTAL
Intervention: Crossed monovision (dominant eye -2.00D, non-dominant eye -0.50D)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional monovision (dominant eye -0.50D, non-dominant eye -2.00D)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Crossed monovision
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional monovision
Number of subjects: 46
Study: 36058514

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention with 10 home visits over 1 year
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention
Number of subjects: 223

Group type: COMPARATOR
Intervention: Certified Asthma Educator (AE‐C) intervention with 2 sessions in a clinic over 1 year
Number of subjects: 223
Study: 33545542

Group type: EXPERIMENTAL
Intervention: Cacao polyphenol-rich chocolate plus water (C)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 48
Study: 36280924

Group type: EXPERIMENTAL
Intervention: 16-gauge epidural needle
Number of subjects: 126

Group type: COMPARATOR
Intervention: 18-gauge epidural needle
Number of subjects: 126
Study: 33726802

Group type: EXPERIMENTAL
Intervention: BiOM powered prosthesis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Unpowered prosthesis
Number of subjects: 12
Study: 35120579

Group type: EXPERIMENTAL
Intervention: Nigella sativa (NS) oil supplementation (two soft gels)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Paraffin oil (control)
Number of subjects: 46
Study: 32225045

Group type: EXPERIMENTAL
Intervention: Health Education Program (HEP) for improving the uptake of HIVST among men in Rwanda
Number of subjects: 0
Study: 35850136

Group type: EXPERIMENTAL
Intervention: Yoga intervention (50 minutes along with conventional medical treatment)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional medical treatment (control group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 62
Study: 32200610

Group type: EXPERIMENTAL
Intervention: CFNB with basal infusion of ropivacaine plus boluses (Group III)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CFNB with continuous infusion of ropivacaine (Group II)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Basal morphine infusion without CFNB (Group I)
Number of subjects: 90